October 30, 2020

BioLineRx Announces Positive Results from Interim Analysis of GENESIS Phase 3 Trial of Motixafortide (BL-8040) in Stem Cell Mobilization

October 29, 2020

BioLineRx Announces Initiation of Phase 2 Clinical Trial in First-Line Metastatic Pancreatic Cancer

August 19, 2020

BioLineRx Achieves Enrollment Target in Phase 3 GENESIS Trial for Planned Interim Analysis